83 related articles for article (PubMed ID: 3954322)
1. Pattern of metastases in human breast carcinoma in relation to estrogen receptor status.
Kamby C; Rose C; Iversen H; Holm NV; Andersen KW; Thorpe SM
Anticancer Res; 1986; 6(1):107-11. PubMed ID: 3954322
[TBL] [Abstract][Full Text] [Related]
2. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
3. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
5. In vitro clonogenic growth and metastatic potential of human operable breast cancer.
Nomura Y; Tashiro H; Hisamatsu K
Cancer Res; 1989 Oct; 49(19):5288-93. PubMed ID: 2766296
[TBL] [Abstract][Full Text] [Related]
6. Estradiol receptor activity in human breast cancer, disease free interval and survival time.
Heise E; Görlich M
Anticancer Res; 1982; 2(1-2):33-6. PubMed ID: 7114801
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological characteristics of estrogen receptor-positive breast cancer].
Song ST
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):426-9. PubMed ID: 3836844
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical localization of estrogen receptor in human breast tissue.
Walker KJ; Bouzubar N; Robertson J; Ellis IO; Elston CW; Blamey RW; Wilson DW; Griffiths K; Nicholson RI
Cancer Res; 1988 Nov; 48(22):6517-22. PubMed ID: 3052804
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
Agoff SN; Swanson PE; Linden H; Hawes SE; Lawton TJ
Am J Clin Pathol; 2003 Nov; 120(5):725-31. PubMed ID: 14608899
[TBL] [Abstract][Full Text] [Related]
12. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors and the pattern of relapse in breast cancer.
Qazi R; Chuang JL; Drobyski W
Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
[TBL] [Abstract][Full Text] [Related]
17. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
18. [Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report (author's transl)].
Cheix F; Biron A; Bailly C; Mayer M; Pommatau E; Saez S
Nouv Presse Med; 1980 Mar; 9(13):933-5. PubMed ID: 7360626
[TBL] [Abstract][Full Text] [Related]
19. Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer.
Horiguchi J; Koibuchi Y; Iijima K; Yoshida T; Takata D; Rokutanda N; Nagaoka R; Oyama T; Iino Y; Morishita Y
Oncol Rep; 2005 Nov; 14(5):1109-16. PubMed ID: 16211272
[TBL] [Abstract][Full Text] [Related]
20. [A randomized study of adjuvant treatments for operable breast cancer patients stratified by estrogen receptor and menopausal status].
Nomura Y; Tsutsui S; Murakami S; Takenaka Y
Gan To Kagaku Ryoho; 1999 Apr; 26(5):643-9. PubMed ID: 10234295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]